We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.33B
AUM Growth
+$70.1M
Cap. Flow
-$89.7M
Cap. Flow %
-3.85%
Top 10 Hldgs %
23.05%
Holding
203
New
5
Increased
30
Reduced
65
Closed
11

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$12.8M
2
IQV icon
IQVIA
IQV
+$8.32M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.79M
4
POOL icon
Pool Corp
POOL
+$7.16M
5
DVN icon
Devon Energy
DVN
+$6.82M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$29.3M
2
ACGL icon
Arch Capital
ACGL
+$24.2M
3
NEE icon
NextEra Energy
NEE
+$11.7M
4
FISV
Fiserv Inc
FISV
+$8.96M
5
ECL icon
Ecolab
ECL
+$6.6M

Sector Composition

Rank Sector Weight
1 Technology 33.52%
2 Industrials 18.51%
3 Financials 15.9%
4 Healthcare 15.48%
5 Consumer Discretionary 6.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATR icon
51
AptarGroup
ATR
$8.55B
$14.2M 0.61%
128,926
– –
DVN icon
52
Devon Energy
DVN
$52.1B
$14.1M 0.61%
230,000
+100,000
+77% +$6.82M
AMZN icon
53
Amazon
AMZN
$2.92T
$13.9M 0.59%
165,000
-8,000
-5% -$790K
META icon
54
Meta Platforms (Facebook)
META
$1.42T
$13.8M 0.59%
115,025
-29,992
-21% -$3.52M
EXLS icon
55
EXL Service
EXLS
$5.14B
$13.5M 0.58%
397,500
-33,500
-8% -$1.16M
SPSC icon
56
SPS Commerce
SPSC
$2.64B
$13.4M 0.58%
104,500
– –
EXAS
57
DELISTED
Exact Sciences
EXAS
$12.6M 0.54%
255,000
-20,000
-7% -$817K
VRTX icon
58
Vertex Pharmaceuticals
VRTX
$121B
$12.1M 0.52%
42,000
-6,010
-13% -$1.83M
AAPL icon
59
Apple
AAPL
$4.54T
$12.1M 0.52%
93,000
-11,018
-11% -$1.57M
JKHY icon
60
Jack Henry & Associates
JKHY
$10.9B
$11.7M 0.5%
66,708
– –
PYPL icon
61
PayPal
PYPL
$48.9B
$11.3M 0.49%
159,000
-21,000
-12% -$1.68M
BAC icon
62
Bank of America
BAC
$435B
$11.3M 0.48%
340,000
-75,000
-18% -$2.58M
RBC icon
63
RBC Bearings
RBC
$17.4B
$11M 0.47%
52,500
– –
BKNG icon
64
Booking.com
BKNG
$149B
$10.5M 0.45%
130,025
-12,500
-9% -$949K
EL icon
65
Estee Lauder
EL
$30.4B
$10M 0.43%
40,500
+23,500
+138% +$5.25M
QCOM icon
66
Qualcomm
QCOM
$155B
$9.79M 0.42%
89,033
-44,015
-33% -$5.15M
HEI icon
67
HEICO Corp
HEI
$49.8B
$9.77M 0.42%
63,583
– –
DXCM icon
68
DexCom
DXCM
$31.5B
$9.74M 0.42%
86,000
-36,000
-30% -$3.95M
GS icon
69
Goldman Sachs
GS
$300B
$9.61M 0.41%
28,000
-7,000
-20% -$2.44M
NFLX icon
70
Netflix
NFLX
$299B
$9.44M 0.41%
320,100
-80,010
-20% -$2.24M
AMD icon
71
Advanced Micro Devices
AMD
$776B
$9.39M 0.4%
145,043
+19,990
+16% +$1.32M
MTCH icon
72
Match Group
MTCH
$9.19B
$9.34M 0.4%
225,000
+75,000
+50% +$3.39M
AAON icon
73
Aaon
AAON
$7.3B
$9.32M 0.4%
185,550
– –
NEE icon
74
NextEra Energy
NEE
$181B
$9.09M 0.39%
108,776
-145,000
-57% -$11.7M
NVDA icon
75
NVIDIA
NVDA
$4.86T
$9.06M 0.39%
620,180
-90,110
-13% -$1.32M
1 2
3
4 5

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return

EULAV Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, EULAV Asset Management held 203 positions worth $2.33B, up 3.1% from $2.26B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

EULAV Asset Management withdrew a net $89.7M in Q4 2022, closing 11 positions and reducing 65 holdings. Its most notable exit was Arch Capital, an estimated $24.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Industrials and Financials.

Against the trend, EULAV Asset Management opened a new position in BioMarin Pharmaceuticals worth $8.59M.

  • EULAV Asset Management's largest Q4 2022 buy was BioMarin Pharmaceuticals: 83,000 shares worth $8.59M.
  • EULAV Asset Management added most to Idexx Laboratories in Q4 2022, an estimated $12.8M increase.
  • EULAV Asset Management's biggest Q4 2022 reduction was Danaher, cutting an estimated $29.3M.
  • EULAV Asset Management fully exited Arch Capital in Q4 2022, selling an estimated $24.2M.
  • EULAV Asset Management's ten largest holdings make up 23% of its $2.33B portfolio in Q4 2022.
  • EULAV Asset Management opened 5 new positions and closed 11 in Q4 2022.
  • EULAV Asset Management's portfolio value rose 3.1% quarter-over-quarter to $2.33B.

Based on EULAV Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.